Skip to results
Modify your search
NARROW
1-20 of 66
Authors: Hiroji Iwata
Journal Article
Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors Open Access
Japanese Journal of Clinical Oncology, Volume 55, Issue 5, May 2025, Pages 547–555, https://doi.org/10.1093/jjco/hyaf033
Published: 23 February 2025
Journal Article
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study Open Access
The Oncologist, Volume 30, Issue 2, February 2025, oyae223, https://doi.org/10.1093/oncolo/oyae223
Published: 11 September 2024
Journal Article
Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives Open Access
Japanese Journal of Clinical Oncology, Volume 55, Issue 1, January 2025, Pages 4–11, https://doi.org/10.1093/jjco/hyae122
Published: 02 September 2024
Journal Article
Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patients Free
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1093–1099, https://doi.org/10.1093/jjco/hyae109
Published: 23 August 2024
Journal Article
Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2–expressing salivary gland carcinoma: a pooled analysis of two phase I studies Open Access
Japanese Journal of Clinical Oncology, Volume 54, Issue 4, April 2024, Pages 434–443, https://doi.org/10.1093/jjco/hyad181
Published: 16 January 2024
Journal Article
EDITOR'S CHOICE
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355 Free
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 5, May 2024, Pages 717–727, https://doi.org/10.1093/jnci/djad240
Published: 09 December 2023
Journal Article
Metastasis-directed therapy for oligometastases in breast cancer Free
Japanese Journal of Clinical Oncology, Volume 53, Issue 10, October 2023, Pages 893–898, https://doi.org/10.1093/jjco/hyad077
Published: 08 July 2023
Journal Article
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial Free
Japanese Journal of Clinical Oncology, Volume 53, Issue 1, January 2023, Pages 4–15, https://doi.org/10.1093/jjco/hyac166
Published: 17 November 2022
Journal Article
Management of breast cancer in older patients Free
Japanese Journal of Clinical Oncology, Volume 52, Issue 7, July 2022, Pages 682–689, https://doi.org/10.1093/jjco/hyac054
Published: 23 April 2022
Journal Article
Comorbid insomnia among breast cancer survivors and its prediction using machine learning: a nationwide study in Japan Open Access
Japanese Journal of Clinical Oncology, Volume 52, Issue 1, January 2022, Pages 39–46, https://doi.org/10.1093/jjco/hyab169
Published: 27 October 2021
Journal Article
Differences in baseline risk estimated by physicians and patients with early breast cancer Free
Japanese Journal of Clinical Oncology, Volume 51, Issue 12, December 2021, Pages 1703–1707, https://doi.org/10.1093/jjco/hyab152
Published: 01 October 2021
Journal Article
A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 10, October 2021, Pages 1498–1508, https://doi.org/10.1093/jjco/hyab131
Published: 21 August 2021
Journal Article
Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) Free
Japanese Journal of Clinical Oncology, Volume 51, Issue 9, September 2021, Page 1479, https://doi.org/10.1093/jjco/hyab124
Published: 23 July 2021
Journal Article
A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) Free
Japanese Journal of Clinical Oncology, Volume 51, Issue 9, September 2021, Pages 1471–1474, https://doi.org/10.1093/jjco/hyab101
Published: 02 July 2021
Journal Article
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3 Open Access
The Oncologist, Volume 26, Issue 8, August 2021, Pages e1339–e1346, https://doi.org/10.1002/onco.13833
Published: 12 June 2021
Journal Article
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer Open Access
JNCI: Journal of the National Cancer Institute, Volume 113, Issue 12, December 2021, Pages 1733–1743, https://doi.org/10.1093/jnci/djab108
Published: 07 June 2021
Journal Article
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3 Open Access
The Oncologist, Volume 26, Issue 7, July 2021, Pages e1143–e1155, https://doi.org/10.1002/onco.13811
Published: 07 June 2021
Journal Article
The significance of biopsy scar excision at the time of skin- or nipple-sparing mastectomy with immediate breast reconstruction Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 8, August 2021, Pages 1212–1218, https://doi.org/10.1093/jjco/hyab065
Published: 04 May 2021
Journal Article
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study Open Access
JNCI: Journal of the National Cancer Institute, Volume 113, Issue 8, August 2021, Pages 1005–1016, https://doi.org/10.1093/jnci/djab004
Published: 01 February 2021
Journal Article
Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A) Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 3, March 2021, Pages 498–503, https://doi.org/10.1093/jjco/hyaa241
Published: 13 January 2021
